Kinetic analysis of human immunodeficiency virus type 1 assembly reveals the presence of sequential intermediates

Journal of Virology

Volumn 74, Issue 13, 2000, Pages 5845-5855

  Tritel, Marc ^a   Resh, Marilyn D ^a,b  

^a Weill Cornell Medical Center   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; HUMAN IMMUNODEFICIENCY VIRUS 1; KINETICS; LENTIVIRINAE; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; VIRUS ASSEMBLY; VIRUS PARTICLE;

ANIMALS; CELL FRACTIONATION; CELL MEMBRANE; CENTRIFUGATION, DENSITY GRADIENT; CHOLIC ACIDS; COS CELLS; CYTOSOL; DETERGENTS; GENE PRODUCTS, GAG; HIV-1; HUMANS; INTRACELLULAR MEMBRANES; JURKAT CELLS; KINETICS; POLYETHYLENE GLYCOLS; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RABBITS; TIME FACTORS; TRIIODOBENZOIC ACIDS; TRYPSIN; VIRUS ASSEMBLY;

EID: 0034086728     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.13.5845-5855.2000     Document Type: Article

References (36)

1. Alland, L., S. M. Peseckis, R. E. Atherton, L. Berthaiume, and M. D. Resh. 1994. Dual myristylation and palmitylation of Src family member p59Fyn affects subcellular localization. J. Biol. Chem. 269:16701-16705.
2. Andersson, S., D. N. Davis, H. Dahlback, H. Jornvall, and D. W. Russell. 1989. Cloning, structure, and expression of the mitochondrial cytochrome P 450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem. 264:8222-8229.
3. Camaur, D., and D. Trono. 1996. Characterization of human immunodeficiency virus type 1 Vif particle incorporation. J. Virol. 70:6106-6111.
4. Campbell, S., and A. Rein. 1999. In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. J. Virol. 73:2270-2279.
5. Campbell, S., and V. M. Vogt. 1995. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J Virol. 69:6487-6497.
6. Choy, E., V. K. Chiu, J. Silletti, M. Feoktistov, T. Morimoto, D. Michaelson, I. E. Ivanov, and M. R. Philips. 1999. Endomembrane trafficking of Ras: the CAAX motif targets proteins to the ER and Golgi. Cell 98:69-80.
7. Dettenhofer, M., and X. F. Yu. 1999. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. J. Virol. 73:1460-1467.
8. Freed, E. O. 1998. HIV-1 Gag proteins: diverse functions in the virus life cycle. Virology 251:1-15.
9. Garnier, L., J. Bradford Bowzard, and J. W. Wills. 1998. Recent advances and remaining problems in HIV assembly. AIDS 12:S5-S16.
10. Garoff, H., R. Hewson, and D. E. Opstelten. 1998. Virus maturation by budding. Microbiol. Mol. Biol. Rev. 62:1171-1190.
11. Gelderblom, H. R., E. H. S. Hausmann, M. Ozel, G. Pauli, and M. A. Koch. 1987. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 156:171-176.
12. Gheysen, D., E. Jabcos, F. DeForesta, C. Thiriart, M. Francotte, D. Thines, and M. DeWilde. 1989. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59:103-112.
13. Gottlinger, H. G., J. G. Sodroski, and W. A. Haseltine. 1989. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:5781-5785.
14. Gottlinger, H. G., T. Dorfman, J. G. Sodroski, and W. A. Haseltine. 1991. Effect of mutations affecting the p6 Gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. USA 88:3195-3199.
15. Henderson, L. E., M. A. Bowers, R. C. Sowder, S. A. Serabyn, D. G. Johnson, J. W. Bess, L. O. Arthur, D. K. Bryant, and C. Fenselau. 1992. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences. J. Virol. 66:1856-1865.
16. Hermida-Matsumoto, L., and M. D. Resh. 1999. Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55gag and p17MA. J. Virol. 73:1902-1908.
17. Kaplan, A. H., M. Manchester, and R. Swanstrom. 1994. The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency. J. Virol. 68:6782-6786.
18. Kaplan, A. H., and R. Swanstrorn. 1991. Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments. Proc. Natl. Acad. Sci. USA 88:4528-4532.
19. Lee, Y. M., B. Liu, and X. F. Yu. 1999. Formation of virus assembly intermediate complexes in the cytoplasm by wild-type and assembly-defective mutant human immunodeficiency virus type 1 and their association with membranes. J. Virol. 73:5654-5662.
20. Lee, Y. M., and X. F. Yu. 1998. Identification and characterization of virus assembly intermediate complexes in HIV-1-infected CD4+ T Cells. Virology 243:78-93.
21. Lingappa, J. R., R. L. Hill, M. L. Wong, and R. S. Hegde. 1997. A multistep, ATP-dependent pathway for assembly of human immunodeficiency virus capsids in a cell-free system. J. Cell Biol. 136:567-581.
22. Morikawa, Y., T. Goto, and K. Sano. 1999. In vitro assembly of human immunodeficiency virus type 1 Gag protein. J. Biol. Chem. 274:27997-28002.
23. Ono, A., and E. O. Freed. 1999. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus. J. Virol. 73:4136-4144.
24. Paillart, J. C., and H. G. Gottlinger. 1999. Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting. J. Virol. 73:2604-2612.
25. Picard, D., and K. R. Yamamoto. 1987. Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J. 6:3333-3340.
26. Resh, M. D., and R. L. Erikson. 1985. Highly specific antibody to Rous Sarcoma Virus src gene product recognizes a novel population of pp60v-src and pp60c-src molecules. J. Cell Biol. 100:409-417.
27. Sandefur, S., V. Varthakavi, and P. Spearman. 1998. The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55gag. J. Virol. 72:2723-2732.
28. Schwartz, S., M. Campbell, G. Nasioulas, J. Harrison, B. K. Felber, and G. N. Pavlakis. 1992. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J. Virol. 66:7176-7182.
29. Gag polyprotein of human immunodeficiency virus type 1 are present in colocalizing membrane-free cytoplasmic complexes. J. Virol. 73: 2667-2674.
30. Spearman, P., R. Horton, L. Rainer, and I. Kuli-Zade. 1997 Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. J. Virol. 71:6582-6592.
31. Spearman, P., and L. Ratner. 1996. Human immunodeficiency virus type 1 capsid formation in reticulocyte lysates. J. Virol. 70:8187-8194.
32. Suomalainen, M., K. Hultenby, and H. Garoff. 1996. Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding. J. Cell Biol. 135:1841-1852.
33. 2-terminal myristoylation and palmitoylation at cysteine-3. J. Cell Biol. 136:1023-1035.
34. Weclewicz, K., M. Ekstrom, K. Kristensson, and H. Garoff. 1998. Specific interactions between retrovirus Env and Gag proteins in rat neurons. J. Virol. 72:2832-2845.
35. Zhou, W., L. J. Parent, J. W. Wills, and M. D. Resh. 1994. Identification of a membrane binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68:2556-2569.
36. Zhou, W., and M. D. Resh. 1996. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J. Virol. 70:8540-8548.